Soligenix Announces Completion of Patient Enrollment in Phase 2 Acute GVHD Prevention Clinical Trial

Soligenix Announces Completion of Patient Enrollment in Phase 2 Acute GVHD Prevention Clinical Trial
Soligenix, Inc. , a late-stage biopharmaceutical company, announced today that patient enrollment has been completed in a randomized, double-blind, placebo-controlled Phase 2 clinical trial of orBec® for the prevention of acute Graft-versus-Host disease after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens. [...]

Vitamin D and Cancer Prevention

Can vitamin D help prevent certain cancers and other diseases such as type 1 diabetes, cardiovascular disease, and certain autoimmune and chronic diseases? To answer these questions and more, UCSD School of Medicine and GrassrootsHealth bring you this innovative series on vitamin D deficiency. Join nationally recognized experts as they discuss the latest research and [...]

Vitamin D and Cardiovascular Disease Prevention

Can vitamin D help prevent certain cancers and other diseases such as type 1 diabetes, cardiovascular disease, and certain autoimmune and chronic diseases? To answer these questions and more, UCSD School of Medicine and grassrootshealth bring you this innovative series on vitamin D deficiency. Join nationally recognized experts as they discuss the latest research and [...]

Canyon Pharmaceuticals announces the availability of Iprivask inhibitor for prevention of DVT

Canyon Pharmaceuticals announces the availability of Iprivask inhibitor for prevention of DVT
Canyon PharmaceuticalsTM (www.canyonpharma.com) today announced the availability of Iprivask (desirudin for injection), the first direct thrombin inhibitor (DTI) approved in the United States by the Food and Drug Administration for the prevention of deep vein thrombosis (DVT), which may lead to pulmonary embolism in [...]

Prostate Cancer Prevention and Screening

Are there modifiable risk factors for prostate cancer? Nutrition? Environment? June Chan, UCSF Division of Cancer Epidemiology, explores the nutritional and hormonal risk factors for prostate cancer. Series: UCSF Mini Medical School for the Public [2/2009] [Health and Medicine] [Show ID: 15574]

Next Page »